Clinical trial
Imiquimod in Children With Plaque Morphea
NCT00147771 · The Hospital for Sick Children, Other · Completed
Key facts
| NCT number | NCT00147771 |
|---|---|
| Title | Imiquimod in Children With Plaque Morphea |
| Official title | Evaluation of the Efficacy and Safety of the Imiquimod 5% Topical Cream in Plaque Morphea: A Prospective, Multiple Baseline, Open Label Pilot Study |
| Lead sponsor | The Hospital for Sick Children, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Scleroderma, Localized |
| Intervention type | Drug |
| Interventions | Imiquimod 5% cream |
| Enrollment | 10 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Sep 7, 2005 |
| Last update posted | Aug 2, 2013 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: